[HTML] plos.org

[HTML][HTML] Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS …, 2014 - journals.plos.org
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of< 5% and available treatments are only minimal effective …
被引用次数：16 相关文章

Implications of Targeted Genomic Disruption of [beta]-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS ONE, 2014 - go.gale.com
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of< 5% and available treatments are only minimal effective …

Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells.

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS …, 2014 - search.ebscohost.com
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of &lt; 5% and available treatments are only minimal effective …

[引用][C] Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS …, 2014 - ui.adsabs.harvard.edu
Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma
Cells - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …

Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells.

PA Olsen, NT Solberg, K Lund, T Vehus… - Plos one, 2014 - europepmc.org
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of< 5% and available treatments are only minimal effective …
[HTML] nih.gov

[HTML][HTML] Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of< 5% and available treatments are only minimal effective …
[PDF] researchgate.net

[PDF][PDF] Implications of Targeted Genomic Disruption of b-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS ONE, 2014 - researchgate.net
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of, 5% and available treatments are only minimal effective …
[PDF] semanticscholar.org

[PDF][PDF] Implications of Targeted Genomic Disruption of b-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS …, 2014 - pdfs.semanticscholar.org
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of, 5% and available treatments are only minimal effective …

Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PloS …, 2014 - pubmed.ncbi.nlm.nih.gov
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of< 5% and available treatments are only minimal effective …
[PDF] psu.edu

[PDF][PDF] Implications of Targeted Genomic Disruption of b-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells

PA Olsen, NT Solberg, K Lund, T Vehus… - PLoS ONE, 2014 - Citeseer
Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an
overall 5-year survival rate of, 5% and available treatments are only minimal effective …